ZyVersa Therapeutics, Inc. (ZVSA) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$5.11M | +32.0% |
| 2024 | -$7.52M | +13.8% |
| 2023 | -$8.72M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$5.11M | +32.0% |
| 2024 | -$7.52M | +13.8% |
| 2023 | -$8.72M | — |